Alliancebernstein L.P. Ptc Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

  • $261 Billion
  • Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 133,283 shares of PTCT stock, worth $6.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133,283
Previous 361,644 63.15%
Holding current value
$6.79 Million
Previous $16.3 Million 58.39%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$41.81 - $57.17 $9.55 Million - $13.1 Million
-228,361 Reduced 63.15%
133,283 $6.79 Million
Q4 2024

Feb 12, 2025
BUY
$34.99 - $52.07 $4.88 Million - $7.27 Million
139,596 Added 62.87%
361,644 $16.3 Million
Q3 2024

Nov 14, 2024
BUY
$30.39 - $37.66 $3.84 Million - $4.76 Million
126,398 Added 132.15%
222,048 $8.24 Million
Q2 2024

Aug 14, 2024
SELL
$24.69 - $40.12 $6.53 Million - $10.6 Million
-264,507 Reduced 73.44%
95,650 $2.92 Million
Q1 2024

May 14, 2024
BUY
$24.15 - $31.95 $159,534 - $211,061
6,606 Added 1.87%
360,157 $10.5 Million
Q4 2023

Feb 14, 2024
BUY
$18.07 - $29.37 $4.02 Million - $6.53 Million
222,483 Added 169.75%
353,551 $9.74 Million
Q3 2023

Nov 14, 2023
SELL
$22.41 - $41.99 $92,530 - $173,376
-4,129 Reduced 3.05%
131,068 $2.94 Million
Q2 2023

Aug 15, 2023
SELL
$40.4 - $59.1 $7.66 Million - $11.2 Million
-189,703 Reduced 58.39%
135,197 $5.5 Million
Q1 2023

May 15, 2023
SELL
$38.16 - $48.86 $897,675 - $1.15 Million
-23,524 Reduced 6.75%
324,900 $15.7 Million
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $7.5 Million - $12.2 Million
223,554 Added 179.03%
348,424 $13.3 Million
Q3 2022

Nov 15, 2022
BUY
$41.85 - $53.85 $1.35 Million - $1.74 Million
32,320 Added 34.92%
124,870 $6.27 Million
Q1 2022

May 13, 2022
BUY
$33.33 - $44.6 $6,666 - $8,920
200 Added 0.22%
92,550 $3.45 Million
Q3 2021

Nov 10, 2021
SELL
$37.01 - $44.74 $22,206 - $26,844
-600 Reduced 0.65%
92,350 $3.44 Million
Q2 2021

Jul 30, 2021
SELL
$37.95 - $49.37 $61.6 Million - $80.2 Million
-1,623,987 Reduced 94.59%
92,950 $3.93 Million
Q1 2021

May 06, 2021
SELL
$46.8 - $68.92 $2.64 Million - $3.89 Million
-56,430 Reduced 3.18%
1,716,937 $81.3 Million
Q4 2020

Feb 08, 2021
BUY
$47.96 - $67.64 $1.66 Million - $2.35 Million
34,709 Added 2.0%
1,773,367 $108 Million
Q3 2020

Nov 12, 2020
BUY
$45.41 - $57.07 $3.4 Million - $4.27 Million
74,858 Added 4.5%
1,738,658 $81.3 Million
Q2 2020

Aug 13, 2020
BUY
$42.56 - $54.98 $2.68 Million - $3.46 Million
62,913 Added 3.93%
1,663,800 $84.4 Million
Q1 2020

May 14, 2020
BUY
$32.37 - $59.36 $49.2 Million - $90.2 Million
1,519,037 Added 1855.88%
1,600,887 $71.4 Million
Q4 2019

Feb 18, 2020
BUY
$32.22 - $50.07 $90,216 - $140,196
2,800 Added 3.54%
81,850 $3.93 Million
Q3 2019

Nov 14, 2019
BUY
$33.82 - $48.17 $37,202 - $52,987
1,100 Added 1.41%
79,050 $2.67 Million
Q2 2019

Aug 14, 2019
BUY
$35.42 - $45.0 $701,316 - $891,000
19,800 Added 34.05%
77,950 $3.51 Million
Q1 2019

May 14, 2019
SELL
$28.09 - $39.49 $1.51 Million - $2.12 Million
-53,800 Reduced 48.06%
58,150 $2.19 Million
Q4 2018

Feb 13, 2019
BUY
$29.83 - $46.51 $1.24 Million - $1.93 Million
41,600 Added 59.13%
111,950 $3.84 Million
Q2 2018

Aug 13, 2018
BUY
$25.7 - $47.88 $539,700 - $1.01 Million
21,000 Added 42.55%
70,350 $2.37 Million
Q3 2017

Nov 13, 2017
BUY
$16.81 - $21.61 $829,573 - $1.07 Million
49,350
49,350 $987,000

Others Institutions Holding PTCT

# of Institutions
287
Shares Held
78.8M
Call Options Held
223K
Put Options Held
156K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.64B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email